AAOpt 2023: The perfect presbyopic patient

News
Article

Post-hoc data helps shine light on better understanding what patient demographics are best suited for presbyopia drops.

Jade Coats, OD, caught up with Optometry Times®' during the 2023 American Academy of Optometry meeting in New Orleans to share a brief overview of a presbyopia poster she was presenting.

Editor's note: This transcript has been lightly edited for clarity.

Jade Coats, OD:

My name is Jade Coats. I'm an optometrist practicing in Northwest Arkansas at McDonald Eye Associates.

At Academy here in New Orleans this week I plan to present on behalf of Orasis regarding some really interesting poster information, some post-hoc data that actually is really helping us understand better the perfect demographics for the presbyopia drops.

Some key takeaways are that surprisingly, but also not surprisingly, there might be a perfect person. And clinically speaking, we know that evaluating the best-corrected distance near acuity is really going to be an important factor in determining who's the best patient for this presbyopia drop.

The next step for this research would be to launch the product and obviously to get our hands on it, get it into the clinics, get it into the patient's hands and have them try it.

Presbyopia has been around; it's not going anywhere. It affects every human blessed to have enough birthdays and so now we have an alternative treatment option and it's just really exciting times but that has to do with pharmaceuticals.

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Karl Stonecipher ASCRS 2025
AnnMarie Hipsley, DPT, PhD, at ASCRS 2025
Neda Shamie, MD; Selina McGee, OD, FAAO, Dipl ABO; and Jacob Lang, OD, FAAO; provided their insights during CIME 2025 on May 4.
At ARVO 2025, Mark Bullimore, MCOptom, PhD, emphasized the need for more accurate, condition-specific tools in evaluating myopic eye growth and treatment efficacy.
Dr Luke Lindsell discusses retinal therapy and geographic atrophy at Controversies in Modern Eye Care 2025
Neda Shamie, MD, speaks on cataract and refractive surgery at CIME 2025.
Dr Selina McGee shares thoughts on pharmacological presbyopia correction at Controversies in Modern Eye Care 2025
Paul Hammond, OD, FAAO, presents a poster at ARVO 2025 on the creation of a conversion factor between 2 OCT devices to monitor glaucoma progression
CIME 25: Dilsher Dhoot, MD, FASRS, is excited about emerging retinal therapies.
© 2025 MJH Life Sciences

All rights reserved.